Screener
Hemab Therapeutics Holdings, Inc. COAG Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s total equity?
- Hemab Therapeutics Holdings, Inc. (COAG) reported total equity of $454.27M in Q2 2026.
- How has Hemab Therapeutics Holdings, Inc.'s total equity changed year-over-year?
- Hemab Therapeutics Holdings, Inc.'s total equity increased by 421.1% year-over-year, from -$141.47M to $454.27M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude